Percutaneous valve repair for mitral regurgitation using the Carillon™ Mitral Contour System™. Description of the method and case report

Kardiologia Polska

Volumn 65, Issue 3, 2007, Pages 272-278

  Siminiak, Tomasz ^a   Firek, Ludwik ^b   Jerzykowska, Olga ^a   Kałmucki, Piotr ^a   Wołoszyn, Maciej ^a   Smuszkiewicz, Piotr ^a   Link, Rafał ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Cardiac Dimensions Inc   (United States)

Author keywords

Coronary veins; Ischaemic heart disease; Mitral regurgitation; Percutaneous techniques

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; INDAPAMIDE; POTASSIUM; RAMIPRIL; SPIRONOLACTONE;

ADULT; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; CORONARY SINUS; CORONARY STENT; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; FATIGUE; FOLLOW UP; HEART DILATATION; HEART LEFT VENTRICLE; HEART VALVE SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MALE; MITRAL VALVE REGURGITATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHLEBOGRAPHY;

EID: 34250711903     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005; 352: 875-83.
2. Tcheng JE, Jackman JD Jr, Nelson CL, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992; 117: 18-24.
3. Byrne MJ, Kaye DM, Mathis M, et al. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation 2004; 110: 3088-92.
4. Maniu CV, Patel JB, Reuter DG, et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 2004; 44: 1652-61.
5. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Ann Intern Med 1992; 117: 10-7.
6. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997; 96: 827-33.
7. Barzilai B, Gessler C Jr, Perez JE, et al. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol 1988; 61: 220-3.
8. Feinberg MS, Schwammenthal E, Shlizerman L, et al. Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol 2000; 86: 903-7.
9. Junker A, Thayssen P, Nielsen B, et al. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology 1993; 83: 14-20.
10. Mehta RH, Supiano MA, Oral H, et al. Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation. Am J Cardiol 2000; 86: 1193-7.
11. Masson S, Gorini M, Salio M, et al. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators. Ital Heart J 2000; 1: 282-8.
12. Kaul S, Spotnitz WD, Glasheen WP, et al. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation 1991; 84: 2167-80.
13. Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001; 37: 641-8.
14. Badhwar V, Bolling SF. Mitral valve surgery in the patient with left ventricular dysfunction. Semin Thorac Cardiovasc Surg 2002; 14: 133-6.
15. Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005; 26: 1188-95.
16. Daimon M, Shiota T, Gillinov AM, et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real - time three-dimensional echocardiographic study in an ovine model. Circulation 2005; 111: 2183-9.
17. Choure AJ, Garcia MJ, Hesse B, et al. In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol 2006; 48: 1938-45.
18. Webb JG, Harnek J, Munt BI, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation 2006; 113: 851-5.
19. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005; 46: 2134-40.
20. Herrmann HC, Rohatgi S, Wasserman HS, et al. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv 2006; 68: 821-8.